CureVac Taps Bayer to Ramp Up COVID-19 Vaccine Rollout
CureVac Taps Bayer to Ramp Up COVID-19 Vaccine Rollout
GALWAY, IRELAND--January 26, 2021--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--Germany's CureVac wants to accelerate the development of its potential COVID-19 vaccine by recruiting pharmaceutical major Bayer to help get it ready for mass rollout.
Within this article: Details CureVac/Bayer alliance, progress of potential COVID-19 vaccine in testing, deal with the EC, related vaccines that have received approval
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects